Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Myocet® in Children With Relapsed or Refractory Non-brainstem Malignant Glioma

NCT02861222 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

NCT NCT02861222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02861222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Myocet® in Children With Relapsed or Refractory Non-brainstem Malignant Glioma
Lead sponsor
Central Hospital, Nancy, France
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2010
Completion date
April 30, 2013
Enrollment
13 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

malignant glioma